Physios biotech is committed to bequeathing/ endowing life science research through the advancement of MPS based on nano and biotechnology.
构建由多孔膜分隔的血管与上皮组织模型。
通过优化细胞类型、细胞外基质(ECM)及培养条件,显著提高目标转运蛋白的表达水平。
依托所构建的MPS平台,可提供底物转运、抑制剂筛选及毒性评估等一系列专业服务。
Create vascular networks with lumen structures.
Using a three-dimensional vascular network, we will evaluate angiogenesis induced by tumor tissue and construct a co-culture method with three-dimensional tissue.
▷ HOME▷ About us▷ Business▷ Technology
▷ Links▷ News▷ Contact▷ Operation and Management Responsibilities of Public Research Funds
Physios Biotech, Inc.〒020-08572-4-23, Kitaiioka, Morioka-shi, Iwate 020-0857, Japan